Puma Biotechnology, Inc.PBYINASDAQ
Loading
Operating Income Growth TrendStable
Percentile Rank85
3Y CAGR-37.3%
5Y CAGR+57.6%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-37.3%/yr
vs +83.7%/yr prior
5Y CAGR
+57.6%/yr
Recent deceleration
Acceleration
-121.0pp
Decelerating
Percentile
P85
Within normal range
vs 5Y Ago
9.7x
Strong expansion
Streak
1 qtr
Consecutive growthStable
| Period | Value |
|---|---|
| Q4 2025 | 78.63% |
| Q3 2025 | 44.26% |
| Q2 2025 | 66.57% |
| Q1 2025 | -70.19% |
| Q4 2024 | -39.47% |
| Q3 2024 | 1113.26% |
| Q2 2024 | 5.22% |
| Q1 2024 | -115.54% |
| Q4 2023 | 72.37% |
| Q3 2023 | 75.49% |
| Q2 2023 | 12.07% |
| Q1 2023 | -56.42% |
| Q4 2022 | 318.55% |
| Q3 2022 | -80.15% |
| Q2 2022 | 1714.19% |
| Q1 2022 | 96.83% |
| Q4 2021 | -163.39% |
| Q3 2021 | 46.17% |
| Q2 2021 | -182.56% |
| Q1 2021 | 280.70% |
| Q4 2020 | 8.09% |
| Q3 2020 | -270.16% |
| Q2 2020 | 150.02% |
| Q1 2020 | -63.47% |
| Q4 2019 | 39.46% |
| Q3 2019 | 44.14% |
| Q2 2019 | -155.58% |
| Q1 2019 | 45.77% |
| Q4 2018 | -64.60% |
| Q3 2018 | 72.73% |
| Q2 2018 | -77.16% |
| Q1 2018 | 63.22% |
| Q4 2017 | 17.87% |
| Q3 2017 | 0.95% |
| Q2 2017 | -6.80% |
| Q1 2017 | -0.41% |
| Q4 2016 | -10.46% |
| Q3 2016 | 0.73% |
| Q2 2016 | 6.69% |
| Q1 2016 | -14.73% |